Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
EGRET: A first-in-human study of the novel antibody-drug conjugate (ADC) AZD9592 as monotherapy or combined with other anticancer agents in patients (pts) with advanced solid tumors
- Authors
- Aggarwal, C[Aggarwal, Charu]; Azzoli, CG[Azzoli, Christopher G.]; Spira, AI[Spira, Alexander I.]; Solomon, BJ[Solomon, Benjamin J.]; Le, XN[Le, Xiuning]; Rolfo, C[Rolfo, Christian]; Planchard, D[Planchard, David]; Felip, E[Felip, Enriqueta]; Wu, YL[Wu, Yi-Long]; Ahn, MJ[Ahn, Myung-Ju]; Seiwert, TY[Seiwert, Tanguy Y.]; Goto, K[Goto, Koichi]; Azaro, A[Azaro, Analia]; Lissa, D[Lissa, Delphine]; Hamid, O[Hamid, Oday]; McGrath, L[McGrath, Lara]; Maudsley, R[Maudsley, Rhiannon]; Arnaldez, FI[Arnaldez, Fernanda I.]; Grenga, I[Grenga, Italia]; Massarelli, E[Massarelli, Erminia]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.